BREAKFAST SEMINAR: Nanomedicine – how to accelerate translation from research to market
• 6 February 2017, Stockholm, 07:30-10:30

07:30 Breakfast is served

8:00-8:30 Key Note presentation
Anna Sandström, Director, Science Relations, AstraZeneca
• Future potential of nanomedicine in the Life Science sector

8:30-9:00 European initiatives to help accelerate translation from research to market
• ENATRANS – Enabling Nanomedicine Translation, Rui Sousa, ENATRANS
• Nanomedicine Translation Advisory Board, Pedro Silva, TAB Management Unit
• How to pitch?, TAB expert
• AceForm4.0 – European collaboration in the formulation area, Lovisa Ringstad, SP

9:00-10:00 PITCH session – Presentation of nanomedicine projects
• FORMAMP – Innovative nanoformulation of peptides, Helena Bysell, SP
• Stable and efficient formulation for amourphous drugs, Sara Frykstrand, Disruptive materials
• Nanoporous silica for advanced drug delivery, Paulina Paszkiewicz, Nanologica
• Cellevate – a nano fiber company, Maximilian Ottosson, Cellevate
• Nanoprobes as optotracers of bacterial biofilms, Ferdinand Choong, Swedish Medical Nanoscience Center, Karolinska Institutet
• Optotracers – now you can really see it!, Susanne Löffler, Ebba Biotech

10:00-10:30 Coffee and networking
The seminar is organized by SP Technical Research Institute of Sweden/RISE in collaboration with SwedNanoTech, ENATRANS and NanoMedNorth.

Venue SP, Drottning Kristinas väg 45, Stockholm. 500 m from subway station Tekniska Högskolan.
Date & Time Monday 6 February 2017, 07:30-10:30
No fee The seminar including breakfast is free of charge.
Questions – general Helena Bysell, SP,
Questions – practical Annika Bergström, SP,
Final date to register 31 January



Vill du eller någon du känner ge din syn på riskbedömningar, reglering och innovationssatsningar i förhållande till nanoteknologi?

Som en del av ett forskningsprojekt om nanoteknolog
i finansierat av MISTRA ( kommer forskare från Göteborgs universitet att undersöka hur intressenter i det svenska samhället ser på nanomaterial och nanoteknologi.

Vi är intresserade av att få kontaktuppgifter
till personer inom ert företag eller organisation som skulle kunna besvara en kort webenkät med frågor om riskbedömningar, reglering och innovationssatsningar i förhållande till nanoteknologi.

Vill ni delta i studien kontakta
så snart som möjligt. Simon kan även ge mer information om forskningsprojektet.
Nanotechnology and nanostructure with nanoparticles, atomic and molecular structure concept

A graphene scientist and NanoMed North member, Jie Sun, associate professor from Chalmers, is searching for people and/or organizations working with biochips.

For further discussions and potential collaboration please reply to


EuroNanoMed III – Joint Transnational Call for Proposals (2017) for “European Innovative Research & Technological Development Projects in Nanomedicine” open.

EuroNanoMed (ENM) is an ERA-NET on Nanomedicine established since 2008 as a platform for funding agencies and ministries to coordinate research programmes with the goal of creating and funding collaborative research projects that can convert research in nanotechnology into practical gains in medicine. Through 7 successful Joint Transnational Calls launched from 2009 to 2016, EuroNanoMed has allocated about 55 Million euros to fund 60 transnational projects in nanomedicine.

Under the umbrella of EuroNanoMed III, the 8th Joint Transnational Call is now opened for funding multilateral innovative research projects on nanomedicine together with the European Commission under the ERA-NET Cofund mechanism:

  • Opening of the submission web tool: 28th November 2016
  • Submission deadline for pre-proposals: 16th January 2017
  • Submission deadline of full proposals: 9th June 2017
  • Available budget for this Call: 14 Mio€ (approx.)

Electronic submission website

Research project consortia who intend to submit a transnational proposal should register as soon as possible and from Nov 28th, at, by clicking on “to register” and following instructions. Electronic proposal submission of proposals on the indicated website is mandatory,


Contact details for the Joint Call Secretariat:

JCS is hosted by the French National Research (ANR)

Postal Address: 50 avenue Daumesnil, 75012 PARIS – France

Contact person for the Joint Call Secretariat: Amélie Vergne ; +33 (0)1 78 09 80 44

We are delighted to advise you that registration for the European Nanomedicine Meeting to be held on 3-4 April 2017 in London is now open.

• Gala Dinner 3 April, The Crypt, St Paul’s

The meeting will provide a forum for international exchange of research to facilitate translation and innovation in nanomedicine research and development. Leading experts and international stakeholders will have the opportunity to discuss opportunities and challenges in this exciting new field of medicine. The meeting will provide delegates with a pulse on the latest developments, as well as a systematic understanding of new nanomedicine paradigms across the development pathway.

This important conference is being hosted by the British Society for Nanomedicine and Society members are entitled to a discount on the conference fees. Register early and don’t miss this opportunity to participate in the second edition of the European Nanomedicine Meeting in London!

For more information and registration – Go to Website


• VanGuards in Nanomedicine: National Research Programmes and Activities
• European Nanomedicine Characterisation Laboratory (EU-NCL)
• Fundamental Nanomedicine
• Preclinical Nanomedicine
• Translational Nanomedicine
• Future needs from Nanomedicine



First International Conference on Advances
in Bio-Materials and Their Applications
31st August – 1st September 2017
• Jury’s Inn, Croydon, UK

Biomaterials have been a growing field of interest for over half a century, spanning industries as diverse as medicine, biology, chemistry, materials science and through to engineering. Biomaterials can be used for clinical purposes, drug discovery, or to further understand tissue and organ development. Another area of concern is the biomaterial polymers market as there is a need for more research and development into biodegradable and bio-compatible polymers.


• Advanced Biomaterials
• Medical and Dental Applications
• Tissue Engineering and Regenerative Medicine
• Polymer and Metallic Biomaterials
• Biomaterials and Nanotechnology
• Biomaterials: Synthesis, Characterization, 3D Printing, Biological Engineering
• Biomaterials for Therapeutic and Investigative Delivery
• Biodegradable Biomaterials
• Scientific Performance of Biomaterials
• Biomaterials for Implants
• Biomechanical Research

• Deadline for abstracts, 16 Jan 2017
• Notification of acceptance, 15 Feb 2017
• Submission of full papers, 30 Jun 2017
• Registration closes, 1 Aug 2017

Go to website • BioMAAP 2017

8th Welcome to BioNanoMed 2017 • International Congress • Nanotechnology in Biology and Medicine< • 20 – 22 March 2017, Krems / Austria

Dear Madam, dear Sir!

We are pleased to announce the 8th International Congress BioNanoMed 2017 – Nanotechnology enables Personalized Medicine which will be held on 20 – 22 March 2017 at the Danube University in Krems / Austria.


In addition to prominent invited speakers a limited number of talks and poster presentations can be accepted. You are cordially invited to submit your abstract!


– Advanced Nanomaterials for Biomedical Applications
– Regenerative Nanomedicine – Nanotechnology and Stem Cells
– Nanotechnology for Detection, Diagnosis, Imaging & Sensing
– NanoPharmaceuticals – an Emerging Era (co-organized by Swiss Academy of Pharmaceutical Sciences – SAPhS)
– Nanotherapy – a promising step to Personalized Nanomedicine
– Clinical Applications of Nanomedicine: Unmet Needs, Challenges, Success Stories & Failures in Clinical Trials
Thematic Sessions
– Brain Targeting and Neurological Nanotherapeutics
– NanoSafety Implementation in Nanomedicine (co-organized by EURO-NanoTox and Nanomedicine Austria)


Danube University Poster Awards 2017 are granted to the three best poster contributions (€ 400 for the first, € 300 for the second and € 200 for the third place)


BioNanoMed 2017 serves as an excellent platform to present your company/institution, to promote your product portfolio and to establish direct links to a broad audience of experts. By becoming an exhibitor or sponsor you will make a great contribution to support the BioNanoMed 2017 congress.


Deadline for oral abstracts: 15 December 2016
Deadline for poster abstracts: 1 March 2017
End of early registration: 26 January 2017
End of online registration: 17 March2017

Please turn to www.bionanomed for all information regarding the BioNanoMed 2017!

If you require further information do not hesitate to contact our conference office at

We are looking forward to your contribution!

Kind regards,
your BioNanoMed 2017 Organizing Team

Mit freundlichen Grüßen / Kind regards
Margit Malatschnig
Project Management BioNanoMed 2017
Techkonnex – High-Tech Promotion
Auhofstraße 70/5
A-1130 Vienna
Phone: +43 699 19215844
Web: <> <>

DRA Symposium 23 September 2016 9:00 – 18:00

Copenhagen Nanomedicine Day 2016

University of Copenhagen, Faculty of Health and Medical
Sciences, PharmaSchool, 2100 Copenhagen Ø
• Morning: Universitetsparken 1, Auditorium Lille UP1
• Lunch and Afternoon: Universitetsparken 2, Auditorium 3
Continue to website, click here



09:00 Welcome to the Nanomedicine Day
Flemming Madsen, Head, Department of Pharmacy, SUND, UCPH

• 09:10 Talk #1: What is Nanomedicine?
Urs Häfeli, Lundbeck Joint Prof, Department of Pharmacy, UCPH &
Faculty of Pharm Sciences, University of British Columbia (UBC), Vancouver, Canada
• 09:30 Talk #2: Mucus as a Barrier to Nanomedicine
Hanne Mørck Nielsen, Prof, Biologics, Department of Pharmacy, SUND, UCPH
• 10:00 Talk #3: High Aspect Ratio Nanostructures for Cellular

Karen Martinez, Assoc Prof, Nano-Science Center & Department of Chemistry, UCPH
•10:30 Coffee Break
• 10:45 Talk #4: Soft Drug Nanocarriers Based on Cubosomes and

Anan Yaghmur, Assoc Prof, Pharm Design & Drug Delivery, SUND,
• 11:15 Talk #5: Synthetic Delivery Systems for Therapeutic

Enrico Mastrobattista, Assoc Prof, Pharmaceutics, University of Utrecht, The Netherlands
• 12:10 Lunch / Poster Setup
•13:10 Introduction to UBC’s Faculty of Pharmacy Research Focus
Mike Coughtrie, Dean, Faculty of Pharmaceutical Sciences, UBC,
Vancouver, Canada
•13:25 Talk #6: Microfluidic Production of Amorphous

Esther Amstad, Assist Prof, Soft Materials Laboratory, Federal
Institute of Technology Lausanne (EPFL), Switzerland
•14:20 Coffee Break

14:35 Talk #7: Potential Applications of Light Robotics in Nanomedicine
Jesper Glückstad, Prof, Department of Photonics Engineering, DTU
• 15:05 Talk #8: Flow Field-Flow Fractionation: A Tool for Liposomal
Size- and Drug Transfer-Analysis

Martin Brandl, Prof, Department of Chemistry, Physics and Pharmacy, University of Southern Denmark, Odense
• 15:35 Talk #9: Design and Delivery of Nanoparticulate Adjuvants
for Subunit Vaccines

Camilla Foged, Assoc Prof, Biologics, Department of Pharmacy, SUND, UCPH
• 16:05 Talk #10: Nanomedicine: Is Targeting our Target?
Gert Storm, Prof, Department of Biomaterials Science and
Technology, University Twente, The Netherlands
• 17:00 Poster Session with Beer and Pretzels
• 17:50 Awarding of Poster Prizes

Marco van de Weert, Assoc Prof, Biologics, Department of Pharmacy, SUND, UCPH
Please register online here

The symposium is organized on behalf of the graduate program in
pharmaceutical sciences, Drug Research Academy, by Prof. Urs Hafeli,
Department of Pharmacy, Faculty of Health and Medical Sciences, University
of Copenhagen. For more info, email
Participation is free of charge and open for attendance by all interested

International Iberian Nanotechnology Laboratory

INL is opening a call of 19 new positions to strengthen its research lines for highly qualified researchers


(4) Senior Staff Researchers

(4) Staff Researchers

(11) Postdoctoral Research Fellows

This call is cofunded by NORTE-45-2015–02 – “Projetos Estruturados de I&D&I”, funded by Norte 2020 – Programa Operacional Regional do Norte.

INL – The International Iberian Nanotechnology Laboratory, was founded under an international legal framework to perform interdisciplinary research and to deploy and articulate nanotechnology for the benefit of society. INL aims to become the world-wide hub for nanotechnology addressing society’s grand challenges with specific emphasis on Aging & Wellbeing, Mobility & Urban Living and a Safe & Secure Society.

The work undertaken by our researchers has a significant impact on people’s lives and societal benefit. The objective is to ensure that staff is employed on the basis of skills and requirements for the job and that there is a mutually beneficial relationship between INL’s expectations and the staff personal and professional career development. INL recruits from all over the world. We find the diversity and multiculturalism of our teams as well as family friendly working practices and benefits to be a great asset and an essential element in cultivating an attractive and inspiring workplace.

Call General Conditions: INL encourages researchers with a distinctive profile at the highest international level in their field of competency to participate and apply to this call.

Employer: International Iberian Nanotechnology Laboratory – INL.

The research programs: The 19 positions are to be allocated into the framework of 3 research programs

• Nanotechnology based functional solutions | Ref.NORTE-01-0145-FEDER-000019

• Advancing cancer research: from basic knowledge to application | Ref. NORTE-01-0145-FEDER-000029

• Frontiers of technology for theranostics of cancer, metabolic and neurodegenerative diseases (FROnTHERA) | Ref. NORTE-01-0145-FEDER-000023

Work Place: International Iberian Nanotechnology Laboratory – INL, Braga, Portugal.

Closing date for applications: For Post-Doctoral Fellows, August 30th 2016, 23:00 (WEST- Western European Summer Time); For Staff Researchers and Consolidated Staff Researchers, September 15th 2016, 23:00 (WEST- Western European Summer Time).

Employment Start Date: Ideally, successful candidates are expected to join the INL by the 4th quarter 2016. Starting date can be negotiated in particular for the Senior Staff Researchers.

Application Procedure: Applications must be formalised online through INL website: , attaching the following documents: a single pdf file containing the candidate’s CV, a statement on research interest (2000-character maximum), list of the 5 most relevant publications, and the contact details of 3 references. Bear in mind that incomplete applications will not be considered for evaluation. The application language is English.


We would like to invite you to participate on the international symposium “CHEMICAL DESIGN – bioMEDICAL APPLICATIONS” held by the Collaborative Research Center CRC 1066 during September 15-16, 2016 in Mainz (Germany). This symposium will focus on the interplay of nanomaterials and the immune system.

The topics will include (1) Chemical Engineering of Novel Nanotherapeutics, (2) Imaging of Immune Processes, (3) Elimination of Immune Tolerance, (4) Activation of the Immune System, (5) Translation in Immunology & Oncology and (6) Interactions with Plasma Proteins.

On these topics, we will have 9 invited talks plus talks from CRC 1066-members presenting their proceedings. A poster session and conference dinner will foster discussions in an informal atmosphere.

Deadline for online registration and poster abstract submission: August 15, 2016.

Detailed information on e.g. invited speakers, venue and registration. Click here.

We are looking forward to welcoming you in Mainz!

With best regards,

Prof. Rudolf Zentel (Speaker CRC 1066)
Prof. Katharina Landfester
Prof. Stephan Grabbe